Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Capecitabine × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Rectal Neoplasms 6 Pancreatic Neoplasms 6 Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Solid Tumors 1 Obesity 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Locally Advanced Rectal Cancer 1 Klatskin Tumor 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Cholangitis, Sclerosing 1 Carcinoma, Hepatocellular 1 Capecitabine 1 Biliary Tract Neoplasms 1 Anus Neoplasms 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06246461 2024-02-07

The Therapeutic Effect of Different Doses of Capecitabine

Jingjiang People's Hospital

Phase NA Completed

Capecitabine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡